Directly Observed Therapy Effective for Treatment-Resistant Hypertension
Regular assessment of adherence to blood pressure-lowering drugs as well as directly observed therapy may be helpful for resolving treatment-resistant hypertension.
All articles by Brandon May
Efficacy of Cardiac Resynchronization for Nonspecific Intraventricular Conduction Delay
Patients with nonspecific intraventricular conduction delay and QRS duration <150 ms or
right bundle branch block may not benefit from cardiac resynchronization therapy with defibrillator, compared with implantable cardioverter-defibrillator therapy alone.
Cognitive Decline Accelerates After Incident Coronary Heart Disease
Accelerated cognitive decline is associated with incident coronary heart disease after, but not before or immediately following, ischemic events.
Alirocumab Safety Profile Similar Regardless of MI, Ischemic Stroke Status
In patients with prior myocardial infarction (MI)/ischemic stroke, treatment with alirocumab is associated with a reduction in low-density lipoprotein cholesterol (LDL-C), as well as reductions in lipoprotein(a), apolipoprotein B, and non-high-density lipoprotein cholesterol (non-HDL-C), according to study results published in the Journal of Clinical Lipidology. In addition, efficacy and safety results were similar in patients…
Risk Prediction Tool Estimates 10-Year, Lifetime Risk for CVD in Healthy People
The LIFEtime-perspective CardioVascular Disease model can accurately estimate individual-level prognosis and treatment-effects in terms of improved 10-year risk, lifetime risk, and life-expectancy free of cardiovascular disease.
Synopsis of the Updated AHA/ACC Guideline for ASCVD Risk Reduction
The AHA/ACC published a new clinical practice guideline on managing cholesterol and provided a risk assessment report on primary prevention of ASCVD.
AHA/HFS Release Scientific Statement on Concomitant Type 2 Diabetes and Heart Failure
The American Heart Association and Heart Failure Society released a joint scientific statement summarizing the effects of type 2 diabetes management on heart failure outcomes.
Mechanical Thrombectomy Device Effectively Treats Intermediate-Risk PE Without Thrombolysis
Mechanical thrombectomy with the FlowTriever system appears to effectively treat intermediate-risk pulmonary embolism.
LDL and DLCNC Score May Identify Familial Hypercholesterolemia
A low-density lipoprotein-cholesterol level >4.9 mmol/L in addition to the Dutch Lipid Clinic Network Criteria score may help identify probable/definite or possible familial hypercholesterolemia.
Pediatric PAH Prognosis Predicted by WHO Functional Class
The incidence/worsening of ≥2 pulmonary arterial hypertension symptoms, World Health Organization Functional Class deterioration, and pulmonary arterial hypertension-related hospitalization were all associated with higher risk for lung transplantation and/or death.
Next post in Pulmonary Vasculature
